4th Quarter - Report

QUADRIPOINT STRATEGIES LLC for AMBIO

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$15,750
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 23, 2020 $15,750 Replaced
4th Quarter - Amendment Feb 11, 2020 $15,750 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

FDA regulation of generic insulin and peptide-based insulin products

LobbyistCovered position, as disclosed
DAVID CRANE Senior Policy Advisor, Majority Leader/Republican Leader Trent Lott, Professional Staff, Senate Commerce Committee, Chairman John McCain, LA/LD Senator Dan Coats

Contacted: Office of the Vice President of the United States; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.